Statistics

Total Visits

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial67

Select a period of time:

Number of views in the range

Views
Lurbinectedin (PM01183) activity in BRCA1/2-associated or unselected metastatic breast cancer. Interim results of an ongoing phase II trial17

Views

Views
April 20254
May 20250
June 20253
July 20255
August 20253
September 20252
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States10
United Kingdom3
Brazil2
Spain1
Hong Kong1
 

Top cities views

Views
Dallas4
Council Bluffs1
Gravesend1
Hong Kong1
Southampton1
São Vicente1
Visconde do Rio Branco1